The global infection control market is expected to grow at a compound annual growth rate (CAGR) of 3.1% from 2022 to 2027 to reach $58.3 billion, according to a recent report from MarketsandMarkets Research. Key factors driving this growth include a high incidence of hospital-acquired infections (HAIs), increasing surgical procedures, a growing geriatric population, and rising rates of chronic disease.
Protective barriers dominate the market currently and are used extensively in surgical settings to prevent contamination and the spread of pathogens. This segment includes medical nonwovens like surgical drapes and gowns as well as other protective equipment. The hospitals and clinics end-user segment is slated for the highest growth rate over the forecast period thanks to increasing HAIs in healthcare settings along with expansion of hospitals in developing countries like India and China.
North America holds the greatest market share due to aging demographics, high disposable incomes, stringent regulations, and advanced healthcare infrastructure. Growth opportunities can also be found by outsourcing operations to emerging markets, especially in Asia Pacific, where rapid development in healthcare is improving access for huge patient populations.
The infection control field will face challenges from alternative disinfection technologies currently in development stages, like electrolyzed water, atmospheric cold plasma, and UV light systems. If successfully commercialized, these could displace traditional manual disinfection methods using liquids and sprays. Market players will need to monitor these disruptive technologies closely.
Key players operating in the space include Sotera Health Company, Steris PLC, Getinge AB, Ecolab Inc., and 3M Company, among others. These companies have substantial market share and have been actively expanding services, acquiring new technology partners, and opening new facilities to meet increasing demand in recent years.
With steady growth expected through 2027, the infection control market presents opportunities for both established leaders and new entrants. Companies that closely track developing technologies while meeting current healthcare needs will be well-positioned to capitalize on this sizeable industry. Offering new solutions to healthcare facilities struggling with HAIs could prove to be especially lucrative in the coming years.
